Stephenson Harwood advised Protium Green Solutions on its £31m Series B funding round. Protium Green Solutions Limited, a green hydrogen energy solutions provider, has completed its...
Protium Green Solutions’ £31 Million Series B Funding Round
Dr. Falk’s Acquisition of Kynos Therapeutics
Stephenson Harwood advised Dr. Falk on the deal. Dr. Falk Pharma GmbH completed the acquisition of Kynos Therapeutics Ltd, a clinical stage biopharmaceutical company focusing on...
BenevolentAI’s Strategic Collaboration with Merck
Stephenson Harwood advised BenevolentAI on strategic collaboration with Merck. BenevolentAI has entered into a strategic collaboration with Merck. This collaboration will leverage BenevolentAI’s comprehensive AI platform...
Bicycle Therapeutics’ Collaboration Agreement with Bayer
Stephenson Harwood advised Bicycle Therapeutics on radiotherapy deal with Bayer. Bayer and Bicycle Therapeutics plc have announced a strategic collaboration agreement to develop, manufacture, and commercialize...
Focusrite plc’s £9.1 Million Acquisition of Sonnox Limited
Stephenson Harwood LLP advised AIM-listed Focusrite plc. Focusrite plc acquired Sonnox Limited. Focusrite is a global music and audio products group supplying hardware and software used...